01 1Ash Stevens LLC
02 1Catalent Micron Technologies, Inc.
03 1Maithri Drugs Private Limited
04 1SK biotek Ireland Limited
01 4Mavacamten
01 1India
02 3U.S.A
NDC Package Code : 48957-0091
Start Marketing Date : 2022-04-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69988-0060
Start Marketing Date : 2022-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 70600-050
Start Marketing Date : 2024-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50193-4423
Start Marketing Date : 2024-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
31
PharmaCompass offers a list of Mavacamten API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mavacamten manufacturer or Mavacamten supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mavacamten manufacturer or Mavacamten supplier.
PharmaCompass also assists you with knowing the Mavacamten API Price utilized in the formulation of products. Mavacamten API Price is not always fixed or binding as the Mavacamten Price is obtained through a variety of data sources. The Mavacamten Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MYK-461; Mavacamten; SAR439152 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MYK-461; Mavacamten; SAR439152, including repackagers and relabelers. The FDA regulates MYK-461; Mavacamten; SAR439152 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MYK-461; Mavacamten; SAR439152 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MYK-461; Mavacamten; SAR439152 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MYK-461; Mavacamten; SAR439152 supplier is an individual or a company that provides MYK-461; Mavacamten; SAR439152 active pharmaceutical ingredient (API) or MYK-461; Mavacamten; SAR439152 finished formulations upon request. The MYK-461; Mavacamten; SAR439152 suppliers may include MYK-461; Mavacamten; SAR439152 API manufacturers, exporters, distributors and traders.
click here to find a list of MYK-461; Mavacamten; SAR439152 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MYK-461; Mavacamten; SAR439152 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for MYK-461; Mavacamten; SAR439152 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture MYK-461; Mavacamten; SAR439152 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain MYK-461; Mavacamten; SAR439152 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MYK-461; Mavacamten; SAR439152 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of MYK-461; Mavacamten; SAR439152 suppliers with NDC on PharmaCompass.
We have 4 companies offering MYK-461; Mavacamten; SAR439152
Get in contact with the supplier of your choice:
